NCT06948786
- Conditions
- Grade 1 Follicular Lymphoma, Grade 2 Follicular Lymphoma, Grade 3a Follicular Lymphoma, +12 more
- Locations
-
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
Clinical trial condition
Hemic and Lymphatic Diseases
Explore clinical trials studying Hemic and Lymphatic Diseases. Study availability and eligibility vary by location and protocol.
21,127 public trials
3,991 recruiting studies
Hemic and Lymphatic Diseases trial results
Recruiting
Allo HSCT for High Risk Hemoglobinopathies
NCT06872333
- Conditions
- Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +8 more
- Locations
-
- Masonic Cancer Center Minneapolis, Minnesota, United States
NCT05890677
- Conditions
- Breast Cancer Lymphedema, Hemic and Lymphatic Diseases, Lymphatic Diseases, +5 more
- Locations
-
- Yale School of Medicine New Haven, Connecticut, United States
- Harvard Medical School Boston, Massachusetts, United States
- Washington University School of Medicine in St. Louis St Louis, Missouri, United States
- Mayo Clinic Rochester, New York, United States
Recruiting
Outcomes in Pediatric and Young Adult B-Cell Malignancies After Commercially Available Immunotherapy
NCT05865301
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
- Locations
-
- Banner University Medical Center - Tucson Tucson, Arizona, United States
- City of Hope Comprehensive Cancer Center Duarte, California, United States
- Stanford University Palo Alto, California, United States
- UCSF (Benioff Children's) San Francisco, California, United States
NCT07490613
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- The First Affiliated Hospital of Soochow University Suzhou, Jiangsu, China
NCT06974786
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
- Locations
-
- University of Alabama at Birmingham Birmingham, Alabama, United States
- Colorado Blood Cancer Institute Denver, Colorado, United States
- University of Iowa Iowa City, Iowa, United States
- University of North Carolina Chapel Hill, North Carolina, United States
NCT05800210
- Conditions
- Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Bone Marrow Diseases, +30 more
- Locations
-
- University of Florida Gainesville, Florida, United States
Recruiting
Dose-finding and Dose Expansion Study of OSE-279 in Subjects With Advanced Solid Tumors or Lymphomas
NCT05751798
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +16 more
- Locations
-
- Institut Jules Bordet Anderlecht, Belgium
- Antwerp University Hospital Edegem, Belgium
- Centre Léon Bérard Lyon, France
- Hopital Saint Joseph Paris, France
Recruiting
AlloHCT With PegINFa for Myelofibrosis
NCT05535764
- Conditions
- Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +3 more
- Locations
-
- Huntsman Cancer Institute at the University of Utah Salt Lake City, Utah, United States
NCT07581704
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- University of Iowa Health Care Iowa City, Iowa, United States